This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
AMAG Pharmaceuticals, Inc. (AMAG)
Q2 2012 Earnings Call
July 26, 2012 8:00 AM ET
Amy Sullivan – VP, IR
Bill Heiden – President and CEO
Frank Thomas – COO
Matt McKinsey – Robert W. Baird
Eun Yang – Jefferies
Carol Werther – Summer Street Research
David Friedman – Morgan Stanley
Joseph Schwartz – Leerink Swannshort
Good afternoon my name is Tiffney and I will be your conference operator today. At this time I would like to welcome everyone to the AMAG Pharmaceuticals second quarter financial results call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. (Operator Instructions). Thank you. Amy Sullivan, Vice President of Investor Relations, you may begin your conference.
Thank you Tiffney. Good morning. I would like to welcome you to the AMAG Pharmaceuticals second quarter 2012 financial results conference call. Before proceeding with this call, please be reminded that any statements we make during the course of this conference call that are other than historical facts are forward-looking statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. We want to emphasize that these forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Please refer to our recent filings with the SEC for a full review of the risks and uncertainties associated with our business.
Let me quickly run through the agenda for this call. Bill Heiden, our President and CEO will review our strategy including our expansion initiative, discuss the business highlights for the quarter and provide an update on our commercial progress with Feraheme. Frank Thomas, our Chief Operating Officer will review our financial performance for the quarter and update the financial guidance for 2012. Bill will provide some closing remarks and then we'll open the call for Q&A. Scott Holmes; our Chief Accounting Officer is also with us this morning and will be available during Q&A. I'll now turn the call over to Bill.